225 related articles for article (PubMed ID: 35252002)
21. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E; Kwong YL
Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
[TBL] [Abstract][Full Text] [Related]
22. How I treat NK/T-cell lymphomas.
Tse E; Kwong YL
Blood; 2013 Jun; 121(25):4997-5005. PubMed ID: 23652805
[TBL] [Abstract][Full Text] [Related]
23. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
[TBL] [Abstract][Full Text] [Related]
24. Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.
Kim SJ; Choi JY; Hyun SH; Ki CS; Oh D; Ahn YC; Ko YH; Choi S; Jung SH; Khong PL; Tang T; Yan X; Lim ST; Kwong YL; Kim WS;
Lancet Haematol; 2015 Feb; 2(2):e66-74. PubMed ID: 26687611
[TBL] [Abstract][Full Text] [Related]
25. Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.
Haverkos BM; Pan Z; Gru AA; Freud AG; Rabinovitch R; Xu-Welliver M; Otto B; Barrionuevo C; Baiocchi RA; Rochford R; Porcu P
Curr Hematol Malig Rep; 2016 Dec; 11(6):514-527. PubMed ID: 27778143
[TBL] [Abstract][Full Text] [Related]
26. The optimal timing of radiotherapy in the combination treatment of limited-stage extranodal natural killer/T-cell lymphoma, nasal type: an updated meta-analysis.
Cui Y; Yao Y; Chen M; Jiang Y; Ren Q
Ann Hematol; 2021 Dec; 100(12):2889-2900. PubMed ID: 34708280
[TBL] [Abstract][Full Text] [Related]
27. Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphoma.
Huang Y; Jia B; Jiang S; Zhou S; Yang J; Liu P; Gui L; He X; Qin Y; Sun Y; Shi Y
J Hematol Oncol; 2017 Jan; 10(1):7. PubMed ID: 28057019
[TBL] [Abstract][Full Text] [Related]
28. Extranodal NK/T-cell lymphoma in Tunisia: clinicopathological features, immunophenotype and EBV infection.
Missaoui N; Mestiri S; Bouriga A; Abdessayed N; Belakhdher M; Ghammem M; Abdelkefi M; Mokni M; Hmissa S
J Egypt Natl Canc Inst; 2019 Oct; 31(1):1. PubMed ID: 32372136
[TBL] [Abstract][Full Text] [Related]
29. [Extranodal NK/T-cell lymphoma, nasal-type, revealed by cutaneous breast involvement].
Fréling E; Granel-Brocard F; Serrier C; Ortonne N; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2015 Feb; 142(2):104-11. PubMed ID: 25554664
[TBL] [Abstract][Full Text] [Related]
30. [Analysis on Clinical Characteristics and Prognosis of 47 Patients with Extranodal NK/T Cell Lymphoma].
Li QH; Yang P; Wang JJ; Dong F; Tian L; Wan W; Ke XY; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):86-90. PubMed ID: 33554802
[TBL] [Abstract][Full Text] [Related]
31. Management of extranodal natural killer/t-cell lymphoma, nasal type.
Chaudhary RK; Bhatt VR; Vose JM
Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):245-52. PubMed ID: 25659751
[TBL] [Abstract][Full Text] [Related]
32. Rhino-Orbital-Cerebral Mycosis and Extranodal Natural Killer or/and T-Cell Lymphoma, Nasal Type.
Li DM; Lun L
Front Med (Lausanne); 2022; 9():851208. PubMed ID: 35783622
[TBL] [Abstract][Full Text] [Related]
33. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
Yokoyama H; Yamamoto J; Tohmiya Y; Yamada MF; Ohguchi H; Ohnishi Y; Okitsu Y; Fukuhara N; Ohba-Ohtsuka R; Kohata K; Ishizawa K; Kameoka J; Harigae H
Leuk Lymphoma; 2010 Aug; 51(8):1509-12. PubMed ID: 20496989
[TBL] [Abstract][Full Text] [Related]
35. Nasal Natural Killer/T-cell Lymphoma with Skin, Eye, and Peroneal Nerve Involvement.
Türker B; Uz B; Işık M; Bektaş O; Demiroğlu H; Sayınalp N; Uner A; Ozcebe Oİ
Turk J Haematol; 2012 Dec; 29(4):413-9. PubMed ID: 24385732
[TBL] [Abstract][Full Text] [Related]
36. Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma.
Song GY; Yoon DH; Suh C; Moon JH; Baek DW; Kim JS; Lee GW; Yi JH; Park Y; Jung KS; Kim SJ; Yang DH; Kim WS
Bone Marrow Transplant; 2021 May; 56(5):1205-1208. PubMed ID: 33277620
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.
Tsuyama N; Asaka R; Dobashi A; Baba S; Mishima Y; Ueda K; Oguchi M; Tsuji H; Hatake K; Takeuchi K
Hematol Oncol; 2018 Feb; 36(1):328-335. PubMed ID: 28695659
[TBL] [Abstract][Full Text] [Related]
38. A case of primary extranodal natural killer/T-cell lymphoma in the orbit and intraocular tissues with cerebrospinal fluid involvement.
Okada A; Harada Y; Inoue T; Okikawa Y; Ichinohe T; Kiuchi Y
Am J Ophthalmol Case Rep; 2018 Sep; 11():37-40. PubMed ID: 29978138
[TBL] [Abstract][Full Text] [Related]
39. A Prospective Phase II Study of Pegaspargase-COEP Plus Radiotherapy in Patients With Newly Diagnosed Extra-Nodal NK/T-Cell Lymphoma.
Hu S; Lin N; Liu J; Sun Y; Liu W; Wang X; Xie Y; Song Y; Wen Y; Zhu J
Front Oncol; 2022; 12():839252. PubMed ID: 35280751
[TBL] [Abstract][Full Text] [Related]
40. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Yamaguchi M; Suzuki R; Oguchi M
Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
